PharmPak, LLC   Report issue

For profit Phase 3
Founded: San Rafael California United States (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2019
NCT04149431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

PharmPak, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

sodium deoxyribonucleate (Derinat) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1